Here are areas where your facility can work to ease patients’ safety concerns during the pandemic. They come from Colleen McCrory, MBA, FACHE, a coach in Huron’s Studer Group advisory firm with 19 years of experience in healthcare...
As of this writing, the novel 2019 coronavirus has infected over 4.6 million Americans and killed over 155,000. Unemployment is at its highest level since the Great Depression, and experts predict mass evictions as financial aid measures run out.
The cost of poor medication adherence is tremendous—nearly $177 billion each year in direct and indirect healthcare costs—but the cost of nonadherence during the COVID-19 pandemic has the potential to be much higher. Medication nonadherence can drive up otherwise avoidable hospital admissions,...
Kevin Ann Huckshorn, PhD, MSN, RN, CADC, ICRC, a national behavioral health consultant with years of experience in hospital settings and now the director of evidence-based practices and programs for Wellpath Recovery Solutions, spoke to Patient Safety Monitor Journal...
Compared with patients hospitalized in urban areas, however, the study found that the risk of death was about 5% higher for patients hospitalized in large towns (with populations of 250,000 to 1 million people), 10% higher for patients in small towns (with populations of 50,000 to 250,000), 16%...
The following Q&A resulted from a conversation PSQH had with Tom Knight, CEO of Georgia-based Invistics, a provider of cloud-based software solutions that improve healthcare inventory visibility and analytics across complex healthcare systems and global supply chains....
The blood test, Called PanSeer, detected cancer in 91% of people who had been asymptomatic when the samples were collected and were diagnosed with cancer one to four years later.
The prevalence of antibodies for people recovering from a mild cases of COVID-19 dropped precipitously after less than three months, according to a research letter published this week in The New England Journal of Medicine.
